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1. Introduction 
Some methylated adenosine derivatives, most 
notably 6-dimethylaminopurine riboside and puro- 
mycin aminonucleoside, have been shown to inhibit 
the autophagic/lysosomal pathway of endogenous 
protein degradation in isolated rat hepatocytes [ 11. 
The mechanism of action of these methylaminopu- 
rines is not known. One possibility is that they might 
exert their effect by preventing the first reaction in 
the autophagic sequence, i.e., the sequestration of 
cytoplasmic material into autophagosomes [2], as do 
the amino acids [3-61. Another possibility is that the 
purines might interfere with the further processing of 
the autophagosomes, including their fusion with lyso- 
somes, as seems to be the case with most other degra- 
dation inhibitors [7]. 
To distinguish between these two possibilities, we 
have undertaken a correlated biochemical and mor- 
phometric analysis of the effects of several adenine 
and adenosine derivatives. The results indicate that 
the methylated aminopurines inhibit endogenous pro- 
tein degradation at the level of autophagic sequestra- 
tion. 
2. Materials and methods 
2.1. Cell preparation and incubation 
Isolated hepatocytes were prepared by the method 
of collagenase perfusion [8] from the liver of 16 h 
starved male Wistar rats (200-300 g). The cells were 
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incubated as suspensions (0.4 ml samples, 50- 100 mg 
wet wt/ml) for 90 min in rapidly shaking centrifuge 
tubes at 37°C. The incubation medium was suspen- 
sion buffer [8] supplemented with pyruvate (20 mM), 
gentamicin (garamycin, 10 pg/ml, Shering Corp., 
Kenilworth NY) and Mg2+ (2 mM). Cell samples were 
divided after incubation; one part was processed for 
biochemistry and the other one for electron micros- 
copy. 
2.2. Measurement of protein degradation 
Endogenous protein degradation was measured as 
the release of [ “C]valine (The Radiochemical Centre, 
Amersham; CFB 75; 260 Ci/mol; 63 mCi/l; 0.24 mM) 
from protein prelabelled in vivo. For this purpose 
50 PCi [r4C]valine was injected into the penis vein of 
the rat 24 h before the isolation of hepatocytes. 
Degradation rates (%) were calculated as percentage 
of the total protein radioactivity at the start of the 
experiment. Sample preparation and analysis was 
performed as in [9,10]. 
2.3. Electron microscopy 
Cell samples were fixed for 1 h at 4°C in 0.1 M 
cacodylate-buffered 1% glutaraldehyde (pH 7.4) con- 
taining 0.1 M sucrose. After rinsing with the glutaral- 
dehyde-free buffer overnight, the samples were post- 
fixed in 1% OsOJO.1 M cacodylate buffer for 30 min, 
dehydrated with ethanol and propylene oxide and 
embedded in Epon. Ultrathin sections were stained 
with lead citrate and examined in a Tesla BS 500 
electron miscroscope. The cytoplasmic volume frac- 
tion of the autophagic/lysosomal compartment was 
measured on electron micrographs (X 12 000 final 
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magnification) by a superimposed double square 
lattice according to [ 111. Statistical evaluation was 
based on volume fraction data obtained from 32 
micrographs of 4 samples. Differences were considered 
significant at p < 0.01 as obtained by Student’s t-test. 
2.4. Chemicals 
All biochemicals were from Sigma (St Louis MO). 
3. Results and discussion 
The autophagic/lysosomal compartment was 
divided into 3 subcompartments by morphological 
criteria. Type I vacuoles (fig.la) with non-destroyed 
content are considered to be autophagosomes [121. 
The electron-lucent type II vacuoles (fig.la) con- 
taining remnants of organelles at various stages of 
destruction, most probably represent secondary 
(auto-)lysosomes [12]. Type III vacuoles (fig.lb,c) 
have a residual body-like appearance with high electron 
density and sometimes with condensed ‘myelinated’ 
material inside. 
The results of the biochemical and morphometric 
measurements are summarized in table 1. A highly 
significant (>SO%) reduction in the endogenous 
degradation rate as well as in the volume fraction of 
autophagosomes (type I vacuoles) could be observed 
in the presence of dimethylaminopurine riboside and 
puromycin aminonucleoside. The other compounds 
suppressed protein degradation and the over-all vol- 
ume fraction of the autophagic/lysosomal compart- 
ment to various degrees, but had no effect on auto- 
phagosomes. 
These data suggest hat dimethylaminopurine 
riboside and puromycin aminonucleoside exert their 
effect on endogenous protein degradation by inhibit- 
ing autophagic sequestration, i.e., the formation of 
autophagosomes. Puromycin, which likewise inhibits 
degradation strongly, apparently has a different 
mechanism of action: unlike the two aforementioned 
compounds, it also inhibits the degradation of exoge- 
nous protein [1], and may be a direct inhibitor of 
lysosomal peptidases [ 131. Most lysosome inhibitors 
tend to cause an accumulation of autophagosomes, 
probably because processing (fusion?) of the latter is 
prevented [7], an effect which might obfuscate any 
inhibition of sequestration by puromycin. 
The availability of inhibitors of autophagic seques- 
tration, other than the amino acids, should be of con- 
siderable utility for the experimental biologist, and 
may help to provide some new insights into the 
mechanisms of autophagy .
Fig.1. Subcompartments of the autophagic/lysosoma.I system in non-treated hepatocytes: (A) examples of type I vacuoles (auto- 
phagosomes, single arrows) and type II vacuoles (secondarylysosomes, double arrows); (B,C) show two kinds of the residual body 
like type III vacuoles (arrows), X 20 600. 
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Table 1 
Effect of adenine, adenosine and some of their methylated derivatives on the degradation of endogenous protein 
and on the autophagic/lysosomaI compartment in isolated rat hepatocytes 
Test compound 
(1O-3 M) 
% Protein 
degraded 
Inhibition (%) 
of degradation 
Volume fraction (mm3/cm3 cytoplasm) 
Vacuole type 
I II III 
Total compartment 
(I + II + III) 
Control 5.06 * 0.17 0.0 14.2 + 0.2 
Adenine 4.40 f 0.25 13.0 13.3 f 0.5 
Adenosine 4.08 f 0.07 19.4 13.2 f 0.3 
Dimethylamino- 
purine 3.23 * 0.08 36.2 12.8 * 1.6 
Puromycin 1.90 t 0.02 62.5 15.4 f 2.3 
Dimethylamino- 
purine riboside 1.43 f 0.07 71.1 2.6 + 0.1 
Puromycin amino- 
nucleoside 2.31 + 0.01 54.4 7.0 f 0.8 
,56.5 t 0.9 0.2 f 0.02 70.9 t 1.0 
46.9 * 0.9 0.9 ?: 0.2 61.1 + 0.9 
59.9 f 1.1 0.3 * 0.02 73.4 * 1.2 
31.4 _+ 4.8 3.2 f 0.7 47.4 + 5.4 
24.4 + 3.2 2.1 f 0.7 41.9 f 4.2 
5.0 f 0.1 0.2 + 0.01 7.8 r 0.2 
15.8 f 2.5 1.4 ?r 0.3 24.2 r 2.9 
Cells were incubated for 90 min at 37°C. Values for endogenous degradation are the mean f SE of 4 samples. Volume fraction 
data are the mean f SE of values taken from 32 micrographs of the cells from the same 4 samples 
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